Atossa Therapeutics posts updated corporate presentation; no specific financial details provided

ATOSSA THERAPEUTICS, INC.

Filed as Exhibit 99.1 on September 26, 2025, but presentation content not included in this filing text.
No new financial figures, pipeline milestones, or guidance changes are extractable from the available text.
Ticker ATOS; company is a clinical-stage biotech focused on breast cancer treatments.
Investors would need to view the actual presentation to assess any material updates.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.